secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2022-07-19T23:59:59+00:00
Accession:  0001493152-22-019817
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience raises $3.5M in private placement; CEO and directors participate
--------------------------------------------------------------------------------

- Raised $3.5M via private placement of 23,333,332 shares at $0.15/share.
- CEO Tom Y. Lee invested $3.26M through affiliates; directors Chen and Rendall invested $93,750 combined.
- Proceeds for general corporate purposes including R&D, admin, working capital.
- Shares issued under exemption from registration (Section 4(a)(2) and Rule 506).
- Disinterested board members approved the transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315222019817/0001493152-22-019817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315222019817/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-019817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer